OR3A3/OR3A2 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

The OR3A3/OR3A2 antibody is a polyclonal rabbit IgG that recognizes both olfactory receptor family 3 subfamily A members 2 (OR3A2) and 3 (OR3A3). These receptors share structural homology, leading to potential cross-reactivity.

  • OR3A2 (UniProt: P47893) is encoded by the OR3A2 gene on chromosome 17 and interacts with odorant molecules to initiate neuronal signaling .

  • OR3A3 (UniProt: Q8NGA8) is a paralog with overlapping epitopes, explaining the antibody’s dual specificity .

Localization in Human Spermatozoa

  • OR3A2 protein was detected in the midpiece of human spermatozoa using immunofluorescence, suggesting a role in calcium signaling during chemotaxis .

  • OR3A3 expression remains less characterized, but cross-reactivity studies indicate its presence in similar cellular compartments .

Functional Insights

  • Ligand activation of OR3A2 induces Ca²⁺ influx in spermatozoa, which is critical for motility and oocyte interaction .

  • Antibody-based inhibition experiments demonstrated that OR3A2/OR3A3 ligands modulate calcium dynamics via T-type voltage-gated channels (inhibited by mibefradil) .

Applications in Experimental Models

  • Western Blotting: Detects OR3A2 at ~35 kDa in transfected Hana3A cells and human sperm lysates .

  • Immunofluorescence: Localizes OR3A2 to the sperm midpiece and flagella .

  • ELISA: Quantifies OR3A2/OR3A3 expression levels in biological samples with high sensitivity (EC₅₀: 0.31–0.58 μg/mL) .

Validation and Quality Control

  • Specificity: Validated using Hana3A cells transfected with OR3A2/OR3A3 plasmids .

  • Cross-Reactivity: Confirmed with peptide-blocking assays, showing reduced signal when pre-incubated with immunogen .

  • Storage: Stable at -20°C in PBS with 50% glycerol and 0.02% sodium azide .

Limitations and Considerations

  • Paralog Cross-Reactivity: Distinguishing OR3A2 from OR3A3 requires gene-specific knockout controls .

  • Tissue Specificity: While validated in spermatozoa, expression in other tissues (e.g., olfactory epithelium) warrants further study .

Product Specs

Buffer
The antibody is provided as a liquid solution in phosphate buffered saline (PBS) containing 50% glycerol, 0.5% bovine serum albumin (BSA), and 0.02% sodium azide.
Form
Liquid
Lead Time
Typically, we are able to ship your order within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. For specific delivery timeframes, please consult your local distributor.
Target Names
OR3A3/OR3A2
Uniprot No.

Q&A

What are OR3A3 and OR3A2 proteins, and why are they significant in research?

OR3A3 and OR3A2 (Olfactory Receptor Family 3, Subfamily A, Members 3 and 2) are olfactory receptors with a molecular weight of approximately 34 kDa . While traditionally associated with olfaction, these receptors have been detected in multiple tissues outside the nose, particularly in human spermatozoa, suggesting non-canonical functions .

Research significance:

  • OR3A3/OR3A2 belongs to a class of ectopically expressed olfactory receptors that may function in chemosensation outside the nasal epithelium

  • Expression in human spermatozoa suggests potential roles in sperm chemotaxis and oocyte location in the female reproductive tract

  • Part of an emerging field studying olfactory receptors as chemosensors in non-olfactory tissues

How do OR3A3/OR3A2 proteins compare to other olfactory receptors expressed outside the nasal cavity?

The human genome contains 387 OR genes, with recent transcriptome analyses revealing expression patterns across multiple tissues :

OR GeneTissue ExpressionFPKM ValuesExpression Confidence
OR3A3Human spermatozoaHigh/selectiveTrue with high confidence
OR2W320+ different tissuesVariable>80% true
OR6B3DRG, TG, retinaHigh/selectiveTrue with high confidence
OR51E2ProstateHighTrue with high confidence

Unlike the canonical "one neuron-one receptor" rule in olfactory neurons, multiple ORs can be expressed in the same non-olfactory cell type. OR3A3 is among the more selectively expressed ORs, particularly enriched in sperm cells compared to other tissues .

What validation methods should be employed to ensure OR3A3/OR3A2 antibody specificity?

Validation of OR3A3/OR3A2 antibodies requires a multi-faceted approach following established guidelines :

Validation ApproachMethodologyStrengthsConsiderations
Positive/negative tissue controlsTesting in tissues with known expression patternsStrong support for well-characterized proteinsRequires known expression pattern
Western blot validationConfirms protein of expected size (34 kDa for OR3A3/OR3A2)Directly evaluates antibody specificityAntibodies may perform differently in WB vs. IHC
Orthogonal validationCompare protein detection with mRNA expression (RNA-Seq/RT-PCR data)Provides correlative evidencemRNA and protein levels don't always correlate
Independent antibody validationTest multiple antibodies targeting different epitopesIdentical patterns provide strong evidenceInconsistent results difficult to interpret
Recombinant expressionTest in transfected cells expressing OR3A3/OR3A2Confirms antibody can detect target proteinDoesn't rule out cross-reactivity in tissues

Example of orthogonal validation: "We detected OR proteins in various compartments of human spermatozoa... and validated the specificity of OR antibodies using Hana3A cells to express recombinant ORs" .

What are the reliability scoring criteria for OR3A3/OR3A2 antibody validation in immunohistochemistry?

Based on established reliability criteria for antibody validation , antibodies can be classified into reliability tiers:

Reliability ScoreDefinitionCriteria Met
EnhancedMeets criteria for enhanced validationAt least one validation method (orthogonal/independent antibody)
SupportedPartial validation evidenceRNA consistency without full orthogonal validation or paired antibodies showing similar patterns
ApprovedLimited validation evidenceRNA consistency but staining pattern inconsistent with literature
UncertainInsufficient validationOnly multitargeting antibodies available or inconsistent results

For OR3A3/OR3A2 antibodies, reliability assessment must consider:

  • High sequence similarity between OR3A3 and OR3A2

  • Limited literature on expression patterns

  • Most commercial antibodies target both proteins ("multitargeting")

What are the optimal protocols for immunolocalization of OR3A3/OR3A2 in human sperm samples?

Based on published methodologies for olfactory receptor localization in sperm :

  • Sample preparation:

    • Purify human sperm and incubate in Ringer's solution

    • Place on poly-L-lysine-coated cover slips

    • Fix with 4% paraformaldehyde

  • Immunostaining protocol:

    • Permeabilize with PBS−/− + 0.1% Triton X-100

    • Block with PBS−/− + 0.1% Triton X-100, 5% NGS, and 1% fish gelatine (1h)

    • Incubate with primary OR3A3/OR3A2 antibody (1:50-1:100 dilution) overnight at 4°C

    • Incubate with Alexa-conjugated secondary antibody and DAPI (45 min, room temperature)

    • Mount in ProLong Gold

  • Imaging:

    • Use confocal fluorescence microscopy for high-resolution localization

    • Capture multiple focal planes to visualize different sperm compartments (head, midpiece, flagellum)

Example findings: "Immunocytochemical staining of human spermatozoa with antibodies revealed OR protein expression in different regions of human spermatozoa. DAPI staining was used to determine the number and location of the cell nuclei."

How can OR3A3/OR3A2 antibodies be applied in different experimental techniques?

Commercial OR3A3/OR3A2 antibodies have been validated for multiple applications :

ApplicationRecommended DilutionProtocol NotesDetection System
Western blot (WB)1:500-1:2000Standard SDS-PAGE and transfer proceduresHRP-conjugated secondary antibody
Immunofluorescence (IF)1:200-1:1000Fixation and permeabilization optimization requiredFluorophore-conjugated secondary antibody
Immunocytochemistry (ICC)1:100-1:500Cell-specific protocols may varyFluorophore-conjugated secondary antibody
ELISA1:5000Indirect ELISA formatHRP-conjugated secondary antibody

Important considerations:

  • Optimization of antibody concentration is essential for each application

  • Cross-validation between applications strengthens reliability

  • Include appropriate positive and negative controls for each application

How should researchers interpret potential cross-reactivity between OR3A3 and OR3A2 when using commercial antibodies?

Given the high sequence homology between OR3A3 and OR3A2, most commercial antibodies detect both proteins :

  • Implications for data interpretation:

    • Immunodetection reflects combined OR3A3/OR3A2 expression

    • Cannot distinguish between individual receptor contributions

    • Results should be reported as "OR3A3/OR3A2" rather than individual receptors

  • Strategies to differentiate between receptors:

    • Complement antibody studies with mRNA analysis using receptor-specific primers

    • Consider mass spectrometry for definitive protein identification

    • Use bioinformatic approaches to identify unique epitopes for future antibody development

  • Addressing cross-reactivity in publications:

    • Clearly state antibody specificity limitations

    • Report the immunogen sequence used for antibody generation

    • Discuss alternative interpretations of results given cross-reactivity potential

What are common challenges in detecting olfactory receptors in non-olfactory tissues, and how can they be addressed?

Detecting olfactory receptors outside the nose presents several challenges :

ChallengeCauseSolution
Low expression levelsCell-type specific expression in heterogeneous tissuesEnrich for specific cell populations; use sensitive detection methods
Potential antisense transcriptsSome OR transcripts exist in antisense orientationUse strand-specific RNA detection methods; validate protein expression
Multiple OR expressionUnlike OSNs, non-olfactory cells may express multiple ORsUse multiple antibodies; perform co-localization studies
Splicing variationsOR transcripts may undergo tissue-specific splicingDesign detection strategies accounting for potential isoforms
Expression dynamicsOR expression may change during cellular processesTemporal studies across development/differentiation

Example approach: "We used stranded mRNA-Seq and detected a class of putative OR transcripts in an antisense orientation, indicating a different function, rather than coding for a functional OR protein. Nevertheless, we were able to detect OR proteins in various compartments of human spermatozoa, indicating distinct functions."

How can researchers identify potential ligands for OR3A3/OR3A2 receptors?

Deorphanization of olfactory receptors requires systematic approaches :

  • Heterologous expression system:

    • Express recombinant OR3A3/OR3A2 in Hana3A cells (specially designed for OR expression)

    • Co-express with accessory proteins like mRTP1S and Gαolf

    • Transfection protocol: "Hana3A cells were grown in 35 mm-cell culture dishes (50% confluence) and transfected with the respective OR plasmid (3 μg), and plasmids coding for mRTP1S (0.5 μg) and Gαolf (0.5 μg) for 48h using standard calcium phosphate precipitation technique"

  • Functional screening:

    • Calcium imaging technique to detect receptor activation

    • Screen with odorant mixtures followed by individual components

    • Example finding: "The deorphanization of OR2W3, OR2H1, and OR10J1 revealed significant activation by the specific odorants nerol, methional, and dimetol, respectively"

  • Confirmation strategies:

    • Dose-response studies with identified ligands

    • Structure-activity relationship studies with chemical analogs

    • Correlation of ligand sensitivity with physiological function

What approaches can determine the functional significance of OR3A3/OR3A2 in human reproduction?

Given the expression of OR3A3/OR3A2 in human spermatozoa, several approaches can investigate their reproductive functions :

  • Localization studies:

    • Determine precise subcellular localization in sperm compartments

    • Compare with other functionally characterized ORs in sperm

    • Example: "OR proteins OR2H1/2 and OR10J1 are localized to different compartments of human spermatozoa... OR2H1/2 in human spermatozoa... different focus (left, flagellum; right, head)... OR10J1 in human spermatozoa... different focus (left, flagellum and midpiece; right, midpiece)"

  • Functional assays:

    • Calcium imaging to detect ligand-induced signaling

    • Sperm chemotaxis assays with identified ligands

    • Correlation of receptor activation with sperm motility parameters

  • Physiological relevance:

    • Compare OR expression in sperm from fertile versus infertile men

    • Test receptor blockade effects on sperm function

    • Investigate potential OR ligands in female reproductive tract fluids

Understanding these receptors could provide insights into reproductive biology and potentially lead to novel fertility treatments or contraceptives.

How might OR3A3/OR3A2 function in SARS-CoV-2 infection mechanisms?

Recent research on SARS-CoV-2 proteins, particularly ORF3a (not to be confused with OR3A3), may inspire investigation of potential interactions between viral proteins and olfactory receptors :

  • Potential research questions:

    • Do olfactory receptors play roles in viral entry or pathogenesis?

    • Could altered OR signaling contribute to COVID-19 anosmia?

    • Are there structural similarities between viral proteins and OR ligands?

  • Experimental approaches:

    • Co-immunoprecipitation to detect protein-protein interactions

    • Functional studies in cell culture models

    • Comparative expression analysis in infected versus non-infected tissues

  • Technical considerations:

    • Specificity of antibodies is crucial for distinguishing between viral ORF3a and olfactory receptors

    • Validation with multiple antibodies targeting different epitopes

    • Complementary approaches beyond antibody-based detection

This represents a speculative but potentially important research direction given the prominence of olfactory dysfunction in COVID-19.

OR3A3/OR3A2 Antibody Characterization Table

Antibody SourceHostImmunogenApplicationsEpitope RegionCross-ReactivityValidation Methods
Commercial RabbitSynthesized peptide from internal regionWB, IF, ELISAInternal regionHumanAffinity purification
Commercial RabbitSynthesized peptide (AA 65-114)WB, IF/ICC, ELISAAA 65-114HumanPeptide affinity chromatography
Research-grade RabbitCustom designedIF/ICCNot specifiedHumanRecombinant expression

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.